194 related articles for article (PubMed ID: 34490238)
1. KIAA1429 and ALKBH5 Oppositely Influence Aortic Dissection Progression
Wang P; Wang Z; Zhang M; Wu Q; Shi F; Yuan S
Front Cell Dev Biol; 2021; 9():668377. PubMed ID: 34490238
[TBL] [Abstract][Full Text] [Related]
2. ALKBH5 promotes lung fibroblast activation and silica-induced pulmonary fibrosis through miR-320a-3p and FOXM1.
Sun W; Li Y; Ma D; Liu Y; Xu Q; Cheng D; Li G; Ni C
Cell Mol Biol Lett; 2022 Mar; 27(1):26. PubMed ID: 35279083
[TBL] [Abstract][Full Text] [Related]
3. KIAA1429 contributes to liver cancer progression through N6-methyladenosine-dependent post-transcriptional modification of GATA3.
Lan T; Li H; Zhang D; Xu L; Liu H; Hao X; Yan X; Liao H; Chen X; Xie K; Li J; Liao M; Huang J; Yuan K; Zeng Y; Wu H
Mol Cancer; 2019 Dec; 18(1):186. PubMed ID: 31856849
[TBL] [Abstract][Full Text] [Related]
4. RNA demethylase ALKBH5 prevents pancreatic cancer progression by posttranscriptional activation of PER1 in an m6A-YTHDF2-dependent manner.
Guo X; Li K; Jiang W; Hu Y; Xiao W; Huang Y; Feng Y; Pan Q; Wan R
Mol Cancer; 2020 May; 19(1):91. PubMed ID: 32429928
[TBL] [Abstract][Full Text] [Related]
5. Gene amplification-driven RNA methyltransferase KIAA1429 promotes tumorigenesis by regulating BTG2 via m6A-YTHDF2-dependent in lung adenocarcinoma.
Zhang C; Sun Q; Zhang X; Qin N; Pu Z; Gu Y; Yan C; Zhu M; Dai J; Wang C; Li N; Jin G; Ma H; Hu Z; Zhang E; Tan F; Shen H
Cancer Commun (Lond); 2022 Jul; 42(7):609-626. PubMed ID: 35730068
[TBL] [Abstract][Full Text] [Related]
6. KIAA1429-mediated m6A modification of CHST11 promotes progression of diffuse large B-cell lymphoma by regulating Hippo-YAP pathway.
Chen X; Lu T; Cai Y; Han Y; Ding M; Chu Y; Zhou X; Wang X
Cell Mol Biol Lett; 2023 Apr; 28(1):32. PubMed ID: 37076815
[TBL] [Abstract][Full Text] [Related]
7. MiR-141-3p promotes malignant progression in prostate cancer through AlkB homolog 5-mediated m
Li X; Liu B; Wang S; Li J; Ge X
Chin J Physiol; 2023; 66(1):43-51. PubMed ID: 36814156
[TBL] [Abstract][Full Text] [Related]
8. ALKBH5 prevents hepatocellular carcinoma progression by post-transcriptional inhibition of PAQR4 in an m6A dependent manner.
Wang W; Huang Q; Liao Z; Zhang H; Liu Y; Liu F; Chen X; Zhang B; Chen Y; Zhu P
Exp Hematol Oncol; 2023 Jan; 12(1):1. PubMed ID: 36609413
[TBL] [Abstract][Full Text] [Related]
9. ALKBH5 Inhibited Cell Proliferation and Sensitized Bladder Cancer Cells to Cisplatin by m6A-CK2α-Mediated Glycolysis.
Yu H; Yang X; Tang J; Si S; Zhou Z; Lu J; Han J; Yuan B; Wu Q; Lu Q; Yang H
Mol Ther Nucleic Acids; 2021 Mar; 23():27-41. PubMed ID: 33376625
[TBL] [Abstract][Full Text] [Related]
10. KIAA1429 regulates cell proliferation by targeting c-Jun messenger RNA directly in gastric cancer.
Miao R; Dai CC; Mei L; Xu J; Sun SW; Xing YL; Wu LS; Wang MH; Wei JF
J Cell Physiol; 2020 Oct; 235(10):7420-7432. PubMed ID: 32052427
[TBL] [Abstract][Full Text] [Related]
11. KIAA1429 regulates the migration and invasion of hepatocellular carcinoma by altering m6A modification of ID2 mRNA.
Cheng X; Li M; Rao X; Zhang W; Li X; Wang L; Huang G
Onco Targets Ther; 2019; 12():3421-3428. PubMed ID: 31118692
[TBL] [Abstract][Full Text] [Related]
12. Mettl14-mediated m6A modification modulates neuron apoptosis during the repair of spinal cord injury by regulating the transformation from pri-mir-375 to miR-375.
Wang H; Yuan J; Dang X; Shi Z; Ban W; Ma D
Cell Biosci; 2021 Mar; 11(1):52. PubMed ID: 33706799
[TBL] [Abstract][Full Text] [Related]
13. KIAA1429 is a potential prognostic marker in colorectal cancer by promoting the proliferation via downregulating WEE1 expression in an m6A-independent manner.
Ma L; Lin Y; Sun SW; Xu J; Yu T; Chen WL; Zhang LH; Guo YC; Wang YW; Chen T; Wei JF; Zhu LJ
Oncogene; 2022 Jan; 41(5):692-703. PubMed ID: 34819634
[TBL] [Abstract][Full Text] [Related]
14. METTL3 promote tumor proliferation of bladder cancer by accelerating pri-miR221/222 maturation in m6A-dependent manner.
Han J; Wang JZ; Yang X; Yu H; Zhou R; Lu HC; Yuan WB; Lu JC; Zhou ZJ; Lu Q; Wei JF; Yang H
Mol Cancer; 2019 Jun; 18(1):110. PubMed ID: 31228940
[TBL] [Abstract][Full Text] [Related]
15. Downregulation of N
Li J; Meng S; Xu M; Wang S; He L; Xu X; Wang X; Xie L
Oncotarget; 2018 Jan; 9(3):3752-3764. PubMed ID: 29423080
[TBL] [Abstract][Full Text] [Related]
16. KIAA1429 facilitates progression of hepatocellular carcinoma by modulating m6A levels in HPN.
Meng Y; Yang W; Li J; Chai W
Heliyon; 2023 Nov; 9(11):e22084. PubMed ID: 38058614
[TBL] [Abstract][Full Text] [Related]
17. A positive feedback loop between AlkB homolog 5 and miR-193a-3p promotes growth and metastasis in esophageal squamous cell carcinoma.
Xue J; Xiao P; Yu X; Zhang X
Hum Cell; 2021 Mar; 34(2):502-514. PubMed ID: 33231844
[TBL] [Abstract][Full Text] [Related]
18. Transcriptome and N6-Methyladenosine RNA Methylome Analyses in Aortic Dissection and Normal Human Aorta.
Zhou X; Chen Z; Zhou J; Liu Y; Fan R; Sun T
Front Cardiovasc Med; 2021; 8():627380. PubMed ID: 34124185
[No Abstract] [Full Text] [Related]
19. ALKBH5 enhances lipid metabolism reprogramming by increasing stability of FABP5 to promote pancreatic neuroendocrine neoplasms progression in an m6A-IGF2BP2-dependent manner.
Chen J; Ye M; Bai J; Gong Z; Yan L; Gu D; Hu C; Lu F; Yu P; Xu L; Wang Y; Tian Y; Tang Q
J Transl Med; 2023 Oct; 21(1):741. PubMed ID: 37858219
[TBL] [Abstract][Full Text] [Related]
20. YY1 is regulated by ALKBH5-mediated m6A modification and promotes autophagy and cancer progression through targeting ATG4B.
Wang S; Nie J; Xu K; Liu Y; Tong W; Li A; Zuo W; Liu Z; Yang F
Aging (Albany NY); 2023 Sep; 15(18):9590-9613. PubMed ID: 37724907
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]